$GERN

$1.15 +$0.00 (0.0%) Close

$GERN Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Company Executives

$GERN Management Team

Mr. Harout Semerjian

President

Chief Executive Officer

Director

Age 54

Compensation -

Sex Male

Ms. Michelle Robertson

Chief Financial Officer

Executive Vice President - Finance

Treasurer

Age 58

Compensation $2.147M USD

Sex Female

Ms. Shannon Odam

Chief People Officer

Senior Vice President

Age 50

Compensation -

Sex Female

Mr. Scott Samuels

Executive Vice President

Chief Legal Officer

Secretary

Age 54

Compensation $3.609M USD

Sex Male

Ms. Melissa Behrs

Executive Vice President - Business Operations

Chief Alliance Officer

Age 61

Compensation $1.152M USD

Sex Female

Dr. Joseph Eid

Executive Vice President - Research and Development

Age 57

Compensation $7.207M USD

Sex Male

Dr. Faye Feller

Executive Vice President

Chief Medical Officer

Age 43

Compensation -

Sex Female

Mr. Edward Koval

Executive Vice President

Chief Business Officer

Age 62

Compensation -

Sex Male

Ms. Elizabeth O'Farrell

Lead Independent Chairman of the Board

Age 60

Compensation $630.7K USD

Sex Female

Mr. Ahmed Elnawawi

Executive Vice President

Chief Commercial Officer

Age -

Compensation -

Sex Male

Mr. Shanthakumar Tyavanagimatt

Senior Vice President

Chief Technology Officer

Age -

Compensation -

Sex Male

Ms. Dawn Schottlandt

Senior Vice President - Investor Relations and Corporate Affairs

Age -

Compensation -

Sex Female

Mr. Bryan Ridgell

Senior Vice President - Portfolio and Project Management and Chief of Staff

Age -

Compensation -

Sex Male

Name / Title	Age	Compensation	Sex
Mr. Harout Semerjian President Chief Executive Officer Director	54	-	Male
Ms. Michelle Robertson Chief Financial Officer Executive Vice President - Finance Treasurer	58	$2.147M USD	Female
Ms. Shannon Odam Chief People Officer Senior Vice President	50	-	Female
Mr. Scott Samuels Executive Vice President Chief Legal Officer Secretary	54	$3.609M USD	Male
Ms. Melissa Behrs Executive Vice President - Business Operations Chief Alliance Officer	61	$1.152M USD	Female
Dr. Joseph Eid Executive Vice President - Research and Development	57	$7.207M USD	Male
Dr. Faye Feller Executive Vice President Chief Medical Officer	43	-	Female
Mr. Edward Koval Executive Vice President Chief Business Officer	62	-	Male
Ms. Elizabeth O'Farrell Lead Independent Chairman of the Board	60	$630.7K USD	Female
Mr. Ahmed Elnawawi Executive Vice President Chief Commercial Officer	-	-	Male
Mr. Shanthakumar Tyavanagimatt Senior Vice President Chief Technology Officer	-	-	Male
Ms. Dawn Schottlandt Senior Vice President - Investor Relations and Corporate Affairs	-	-	Female
Mr. Bryan Ridgell Senior Vice President - Portfolio and Project Management and Chief of Staff	-	-	Male

Board of Directors

From the proxy statement filed Apr 7, 2026

Directors

serving now

Independent

8 of 9

stated in the proxy

Average tenure

6.1 years

from year joined

CEO also chairs the board

Elizabeth G. O’Farrell

Director	Age	On board	Independent	Committees	Other public boards	Pay
Susan M. Molineaux	72	2012 14 years	Independent	Compensation Committee · Chair	None stated	Not stated
Patricia S. Andrews	68	2026 0 years	Independent	None stated	Glenmark Pharmaceuticals Limited, Oncolytics Biotech Inc.	Not stated
Constantine Chinoporos	59	2026 0 years	Independent	None stated	None stated	Not stated
Dawn C. Bir	55	2019 7 years	Independent	Compensation Committee	Cassava Sciences, Inc., Soleno Therapeutics, Inc.	Not stated
John F. McDonald	65	2022 4 years	Independent	None stated	None stated	Not stated
Elizabeth G. O’Farrell Board chair	61	2019 7 years	Independent	Audit Committee · Chair	LENSAR, Inc., Genmab A/S, SpyGlass Pharma, Inc.	Not stated
Harout Semerjian CEO	55	2025 1 year	Not independent	None stated	None stated	Paid as CEO
Robert J. Spiegel	76	2010 16 years	Independent	None stated	Ayala Pharmaceuticals, RenovoRx	Not stated
V. Bryan Lawlis Leaving at the meeting	Not stated	Not stated	Independent	None stated	None stated	Not stated

Each director opens the passage of the proxy that names them. "Not stated" means the proxy does not say; it never means "no". Pay is the proxy's Director Compensation table; the CEO is paid as an executive.

No related-party transactions disclosed

The proxy filed Apr 7, 2026 describes a review policy but reports no transactions.

Read the policy in the proxy

Comments

Company Executives

$GERN Management Team

Mr. Harout Semerjian

Ms. Michelle Robertson

Ms. Shannon Odam

Mr. Scott Samuels

Ms. Melissa Behrs

Dr. Joseph Eid

Dr. Faye Feller

Mr. Edward Koval

Ms. Elizabeth O'Farrell

Mr. Ahmed Elnawawi

Mr. Shanthakumar Tyavanagimatt

Ms. Dawn Schottlandt

Mr. Bryan Ridgell

Board of Directors

Related-party transactions

No related-party transactions disclosed